354 related articles for article (PubMed ID: 21242773)
1. Development and psychometric evaluation of the chemotherapy-induced peripheral neuropathy assessment tool.
Tofthagen CS; McMillan SC; Kip KE
Cancer Nurs; 2011; 34(4):E10-20. PubMed ID: 21242773
[TBL] [Abstract][Full Text] [Related]
2. The reliability and validity of a modified total neuropathy score-reduced and neuropathic pain severity items when used to measure chemotherapy-induced peripheral neuropathy in patients receiving taxanes and platinums.
Smith EM; Cohen JA; Pett MA; Beck SL
Cancer Nurs; 2010; 33(3):173-83. PubMed ID: 20357656
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy-induced peripheral neuropathy: assessment of oncology nurses' knowledge and practice.
Binner M; Ross D; Browner I
Oncol Nurs Forum; 2011 Jul; 38(4):448-54. PubMed ID: 21708535
[TBL] [Abstract][Full Text] [Related]
4. The psychometric properties of the Turkish version of the Chemotherapy-Induced Peripheral Neuropathy Assessment Tool (CIPNAT).
Kutlutürkan S; Öztürk ES; Arıkan F; Kahraman BB; Özcan K; Uçar MA
Eur J Oncol Nurs; 2017 Dec; 31():84-89. PubMed ID: 29173832
[TBL] [Abstract][Full Text] [Related]
5. Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS).
Binda D; Vanhoutte EK; Cavaletti G; Cornblath DR; Postma TJ; Frigeni B; Alberti P; Bruna J; Velasco R; Argyriou AA; Kalofonos HP; Psimaras D; Ricard D; Pace A; Galiè E; Briani C; Dalla Torre C; Lalisang RI; Boogerd W; Brandsma D; Koeppen S; Hense J; Storey D; Kerrigan S; Schenone A; Fabbri S; Rossi E; Valsecchi MG; Faber CG; Merkies IS; ; Galimberti S; Lanzani F; Mattavelli L; Piatti ML; Bidoli P; Cazzaniga M; Cortinovis D; Lucchetta M; Campagnolo M; Bakkers M; Brouwer B; Boogerd W; Grant R; Reni L; Piras B; Pessino A; Padua L; Granata G; Leandri M; Ghignotti I; Plasmati R; Pastorelli F; Heimans JJ; Eurelings M; Meijer RJ; Grisold W; Lindeck Pozza E; Mazzeo A; Toscano A; Russo M; Tomasello C; Altavilla G; Penas Prado M; Dominguez Gonzalez C; Dorsey SG
Eur J Cancer; 2013 Sep; 49(13):2910-8. PubMed ID: 23668917
[TBL] [Abstract][Full Text] [Related]
6. Background noise: the experience of chemotherapy-induced peripheral neuropathy.
Bakitas MA
Nurs Res; 2007; 56(5):323-31. PubMed ID: 17846553
[TBL] [Abstract][Full Text] [Related]
7. The total neuropathy score: a tool for measuring chemotherapy-induced peripheral neuropathy.
Smith EM; Beck SL; Cohen J
Oncol Nurs Forum; 2008 Jan; 35(1):96-102. PubMed ID: 18192158
[TBL] [Abstract][Full Text] [Related]
8. Psychometric evaluation of two scales assessing functional status and peripheral neuropathy associated with chemotherapy for ovarian cancer: a gynecologic oncology group study.
Almadrones L; McGuire DB; Walczak JR; Florio CM; Tian C
Oncol Nurs Forum; 2004 May; 31(3):615-23. PubMed ID: 15146227
[TBL] [Abstract][Full Text] [Related]
9. Statistical identification of predictors for peripheral neuropathy associated with administration of bortezomib, taxanes, oxaliplatin or vincristine using ordered logistic regression analysis.
Kanbayashi Y; Hosokawa T; Okamoto K; Konishi H; Otsuji E; Yoshikawa T; Takagi T; Taniwaki M
Anticancer Drugs; 2010 Oct; 21(9):877-81. PubMed ID: 20679888
[TBL] [Abstract][Full Text] [Related]
10. The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20.
Postma TJ; Aaronson NK; Heimans JJ; Muller MJ; Hildebrand JG; Delattre JY; Hoang-Xuan K; Lantéri-Minet M; Grant R; Huddart R; Moynihan C; Maher J; Lucey R;
Eur J Cancer; 2005 May; 41(8):1135-9. PubMed ID: 15911236
[TBL] [Abstract][Full Text] [Related]
11. Development and validity testing of the neuropathy total symptom score-6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy.
Bastyr EJ; Price KL; Bril V;
Clin Ther; 2005 Aug; 27(8):1278-94. PubMed ID: 16199253
[TBL] [Abstract][Full Text] [Related]
12. Reliability and validity of the Japanese version of the Recovery Assessment Scale (RAS) for people with chronic mental illness: scale development.
Chiba R; Miyamoto Y; Kawakami N
Int J Nurs Stud; 2010 Mar; 47(3):314-22. PubMed ID: 19679304
[TBL] [Abstract][Full Text] [Related]
13. [Chemotherapy-induced peripheral neuropathy].
Noguchi E; Maeda Y
Gan To Kagaku Ryoho; 2011 Nov; 38(11):1773-6. PubMed ID: 22083183
[TBL] [Abstract][Full Text] [Related]
14. QUOTEchemo: a patient-centred instrument to measure quality of communication preceding chemotherapy treatment through the patient's eyes.
van Weert JC; Jansen J; de Bruijn GJ; Noordman J; van Dulmen S; Bensing JM
Eur J Cancer; 2009 Nov; 45(17):2967-76. PubMed ID: 19615889
[TBL] [Abstract][Full Text] [Related]
15. Psychometric testing of the Health Quotient questionnaire: a measure of self-reported holistic health.
Guo J; Dixon JK; Whittemore R; He GP
J Adv Nurs; 2010 Mar; 66(3):653-63. PubMed ID: 20423400
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal validation and comparison of the Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life-Chemotherapy-Induced Peripheral Neuropathy Questionnaire (EORTC QLQ-CIPN20) and the Functional Assessment of Cancer-Gynecologic Oncology Group-Neurotoxicity subscale (FACT/GOG-Ntx).
Cheng HL; Molassiotis A
Asia Pac J Clin Oncol; 2019 Feb; 15(1):56-62. PubMed ID: 29873180
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of the comprehensive assessment scale for chemotherapy-induced peripheral neuropathy in survivors of cancer.
Kanda K; Fujimoto K; Mochizuki R; Ishida K; Lee B
BMC Cancer; 2019 Sep; 19(1):904. PubMed ID: 31506070
[TBL] [Abstract][Full Text] [Related]
18. Trust in Nurses Scale: construct validity and internal reliability evaluation.
Radwin LE; Cabral HJ
J Adv Nurs; 2010 Mar; 66(3):683-9. PubMed ID: 20423403
[TBL] [Abstract][Full Text] [Related]
19. Psychometric Properties of the Korean Version of the Chemotherapy-Induced Peripheral Neuropathy Assessment Tool.
Jung MS; Kim M; Cha K; Cui X; Lee JW
Res Theory Nurs Pract; 2022 Sep; ():. PubMed ID: 36096521
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy-Induced Peripheral Neuropathy Assessment Tools: A Systematic Review.
Haryani H; Fetzer SJ; Wu CL; Hsu YY
Oncol Nurs Forum; 2017 May; 44(3):E111-E123. PubMed ID: 28635977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]